This site makes use of Javascript, please enable your web browser to allow Javascript. Thank you.
Andrew Bauer

Andrew Bauer

Complex Commercial Litigation Department

New York
T: +212 836 7669
F: +1 212 836 8689

icon Download vCard

Legal Services


  • University of Michigan Law School
  • University of Pennsylvania

Bar Admission(s)

  • New York
  • US Court of Appeals for the Second Circuit
  • US District Court for the Southern and Eastern Districts of New York

Andrew Bauer is a partner in the Complex Commercial Litigation Department and a member of the White Collar Litigation and Internal Investigations Group.

Prior to joining the firm, Andrew was an Assistant United States Attorney in the Criminal Division of the United States Attorney’s Office for the Southern District of New York (SDNY) from 2010 to 2016. In this role, he investigated and prosecuted cases involving a wide variety of financial crimes and healthcare fraud offenses. Most recently, as a member of the Securities and Commodities Fraud Task Force, Andrew focused primarily on securities fraud, insider trading, investment advisor fraud, market manipulation, wire fraud, money laundering and Foreign Corrupt Practices Act (FCPA) violations. Andrew has worked closely with multiple government agencies, including the SEC, CFTC, FTC, FINRA and FDA. Andrew has prosecuted alleged securities fraud at public (Fortune 500) and private companies, hedge funds, investment banks, broker-dealers, investment advisors and Government agencies.

While at the SDNY, Andrew was also one of the few criminal prosecutors handling pharmaceutical fraud cases with allegations of off-label promotion and violations of the anti-kickback statute.

Notably, Andrew tried to verdict a number of trials, including nine federal criminal trials in the US District Court for the SDNY, all of which led to convictions. Andrew has also briefed and argued dozens of appeals before the United States Court of Appeals for the Second Circuit.

In addition to his service at the US Attorney’s Office, where he also served in the Violent Crimes Unit prosecuting RICO, murder, robbery, firearm and narcotics offenses, Andrew was an associate at Kaye Scholer for five years where he worked on major criminal and civil investigations. Andrew focused primarily on representing pharmaceutical companies facing civil and criminal government investigations, advising on compliance matters and conducting internal investigations. 

Before entering law, Andrew worked as a trader and analyst in the convertible bond and risk arbitrage groups at a hedge fund. He was also a project leader at an Internet venture company where he managed business strategy and brand management for portfolio clients.

He earned his JD from the University of Michigan Law School and his BA from the University of Pennsylvania, with a joint major through the Wharton School of Business.